Jane Street’s SpringWorks Therapeutics SWTX Stock Holding History

Jane Street’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-61,800	Closed	-$2.9M	–	11740
2025 Q2	$2.9M	Sell	61,800 -213,600	-78%	-$9.5M	﹤0.01%	3810
2025 Q1	$12.2M	Buy	275,400 +261,300	+1,853%	+$12M	﹤0.01%	1764
2024 Q4	$509K	Sell	14,100 -16,900	-55%	-$590K	﹤0.01%	6740
2024 Q3	$993K	Buy	+31,000	New	+$1.16M	﹤0.01%	5900
2024 Q1	–	Sell	-56,000	Closed	-$2.04M	–	10054
2023 Q4	$2.04M	Buy	+56,000	New	+$1.46M	﹤0.01%	4291
2023 Q3	–	Sell	-8,300	Closed	-$218K	–	9365
2023 Q2	$218K	Buy	+8,300	New	+$218K	﹤0.01%	7581
2023 Q1	–	Sell	-27,000	Closed	-$702K	–	9903
2022 Q4	$702K	Sell	27,000 -31,900	-54%	-$786K	﹤0.01%	5574
2022 Q3	$1.68M	Buy	+58,900	New	+$1.69M	﹤0.01%	4506
2022 Q2	–	Sell	-13,500	Closed	-$762K	–	10838
2022 Q1	$762K	Buy	+13,500	New	+$773K	﹤0.01%	6694

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jane Street's SWTX Position: Q3 2025 in Review

Jane Street sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 70,814 shares — an estimated $3.33M sold.

Jane Street first reported a position in SWTX in Q3 2019 and held it in 17 quarters. The position peaked at $28.6M in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Jane Street reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Jane Street sold 70,814 SpringWorks Therapeutics shares in Q3 2025, an estimated $3.33M.
Jane Street first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 17 quarters.
Jane Street's SpringWorks Therapeutics position peaked at $28.6M in Q1 2024.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.